Not independent
Tenure on this board
13.0 yrs
Meeting calendar
PAHC · Annual meeting · Tuesday, November 3, 2026
Phibro Animal Health Corp
3 nominees · 2 ballot items.
Stockholders will vote on the election of three Class I directors and ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm for fiscal year 2027.
Market cap
$1.6B
1Y TSR
-2.4%
Board grade
A
Record date
Sep 11, 2026
Filing
DEF 14A
Filed Sep 18, 2026 · DEF 14A
Proposals
On the ballot2
- 1
Election of Class I Directors
ManagementBoard: FORElect Daniel M. Bendheim, Jonathan Bendheim and Sam Gejdenson as three Class I directors, each to serve until the 2029 Annual Meeting and until a successor is duly elected and qualified.
- 2
Ratification of Selection of PricewaterhouseCoopers LLP
ManagementBoard: FORRatify the Audit Committee’s selection of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending June 30, 2027.
Director elections
Nominees on the ballot3
Not independent
Tenure on this board
42.8 yrs
Independent
Tenure on this board
22.8 yrs
Ownership
Latest 13F quarterTop institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | 5.8% | 2,344,956 | $74M |
| 2 | FMR LLC | 5.4% | 2,177,501 | $68M |
| 3 | STATE STREET CORP | 2.6% | 1,038,382 | $33M |
| 4 | MILLENNIUM MANAGEMENT LLC | 2.3% | 936,701 | $29M |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 2.3% | 923,318 | $29M |
| 6 | FMR LLC | 1.9% | 758,905 | $24M |
| 7 | LORD, ABBETT & CO. LLC | 1.6% | 653,305 | $21M |
| 8 | BlackRock, Inc. | 1.4% | 582,784 | $18M |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | 1.4% | 580,898 | $18M |
| 10 | VANGUARD PORTFOLIO MANAGEMENT LLC | 1.3% | 508,486 | $16M |
Filings
Phibro Animal Health Corp proxy statements and SEC reports
Peers
Nearest market capOther Healthcare sector meetings6
Upcoming shareholder meetings at Phibro Animal Health Corp’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Personalis IncPSNL
Special meeting·Nov 30, 2026·$1.7B
Innovage Holding CorpINNV
Annual meeting·Dec 3, 2026·$1.2B
Zymeworks IncZYME
Annual meeting·Dec 15, 2026·$2.0B
Wave Life Sciences IncWVE
Annual meeting·Nov 12, 2026·$708M
Entera Bio LtdENTX
Special meeting·Nov 24, 2026·$554M
Angiodynamics IncANGO
Annual meeting·Nov 17, 2026·$495M
Reference
Frequently asked questions
- When is the Phibro Animal Health Corp 2026 annual meeting?
- Phibro Animal Health Corp (PAHC) holds its 2026 annual shareholder meeting on Tuesday, November 3, 2026.
- What is the record date for the Phibro Animal Health Corp 2026 meeting?
- The record date for the Phibro Animal Health Corp 2026 meeting is Friday, September 11, 2026. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for Phibro Animal Health Corp's 2026 meeting?
- The board is presenting 3 director nominees at the Phibro Animal Health Corp 2026 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the Phibro Animal Health Corp 2026 meeting?
- Shareholders will vote on 2 proposals at the Phibro Animal Health Corp 2026 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.